This proposed bill (HR 220) would expand VA healthcare benefits to cover infertility treatments like in vitro fertilization (IVF) and fertility preservation services for veterans with infertility or at risk of infertility (e.g., due to medical treatments), and their partners. It limits VA coverage to three successful IVF cycles or ten attempts, requires consent from veterans, partners, and donors, and allows use of donated eggs or embryos. Partners would receive travel reimbursement as if they were veterans, and temporary rules during implementation will immediately allow partners to access care without marriage requirements. The bill clarifies VA isn’t required to cover maternity care beyond existing rules and defers full implementation until VA issues final regulations within one year of enactment.
This bill requires the Comptroller General to study and report on menopause care provided by the Department of Veterans Affairs (VA) to women veterans experiencing perimenopause, menopause, or genitourinary syndrome of menopause. The study will examine current VA protocols for diagnosis, treatment, provider training, veteran access to care, outreach efforts, and quality of care, including veteran feedback. The VA Secretary must then develop a strategic plan within six months of the report's release to improve menopause care access and quality for women veterans under VA healthcare programs.
This bill, titled "Emergency Border Control Resolution," is actually a budget resolution establishing fiscal year 2025-2034 budget levels for the U.S. government. It sets detailed revenue, spending, and deficit targets across various government functions, including defense, health, and social programs. The resolution includes reconciliation instructions for committees to adjust laws within their jurisdictions to meet deficit targets. The title appears to be a political label rather than an accurate description of the bill's content, as it contains no actual border control provisions.
S.68, the Complete COVID Collections Act, extends the deadline for prosecuting fraud related to pandemic relief programs to 10 years and streamlines collection processes for small business loans. It requires the Small Business Administration to refer claims under $100,000 to the Treasury for collection, mandates monthly reports to Congress on collection efforts, and demands monthly DOJ reports detailing fraud prosecutions and recovered funds. The bill directly affects businesses that received CARES Act loans, restaurant grants, or venue operator funds, as well as the SBA, Treasury, and DOJ. Key provisions include standardizing fraud enforcement timelines across all covered programs and requiring public transparency on recovered funds through the Pandemic Response Accountability Committee.
Alpha-gal Allergen Inclusion Act This bill expands the definition of major food allergen to include galactose-alpha-1,3-galactose (commonly known as alpha-gal ). Under current law, food labels generally must identify each major food allergen found in labeled food products. (Certain tick bites cause an allergic condition known as alpha-gal syndrome that can result in an allergy to the alpha-gal molecule, which is found in red meat and other products made from mammals.)
HR 1160, the Health Care Provider Shortage Minimization Act of 2025, changes tax treatment for temporary healthcare providers. It clarifies that locum tenens physicians (including doctors of medicine, dentistry, or podiatry) and advanced care practitioners (like nurse practitioners and physician assistants) working temporarily at a site for up to one year are not treated as employees for tax purposes. This means their pay is not considered employment income, and neither the facility, contracting agency, nor payor is treated as their employer. The law applies to services performed under written contracts specifying this tax status, effective after the bill's enactment.
This bill clarifies that states may use direct primary care arrangements under Medicaid, where patients pay a fixed fee for primary care only (not for other services). It requires the HHS Secretary to issue implementation guidance within one year and submit a report to Congress within two years analyzing state contracting practices and outcomes of these arrangements. The bill directly affects state Medicaid programs and managed care organizations by removing barriers to adopting this payment model. It does not change Medicaid eligibility, funding, or cost-sharing requirements. The focus is on enabling states to explore new primary care delivery methods through clear regulatory guidance.
The HALT Fentanyl Act (HR 27) creates a new category of Schedule I controlled substances for "fentanyl-related substances" defined by specific chemical modifications to fentanyl. This law directly affects researchers, medical professionals, and law enforcement by expanding the legal definition of fentanyl-related substances to include many structurally similar compounds. Key provisions include streamlined registration processes for research on these substances, allowing researchers to conduct studies with expedited procedures if related to FDA-approved drug development or government-funded research. The bill requires the Attorney General to issue implementing rules within six months and includes penalties for violations involving these substances.
This bill would abolish the United States Agency for International Development (USAID) by ending all federal funding for its operations. Starting on the bill's enactment date, no funds may be used for USAID's functions under the Foreign Assistance Act or other laws, and any unused funds as of the day before enactment would be rescinded. All remaining USAID assets and liabilities would be transferred to the Secretary of State. The bill directly affects USAID's ability to carry out international development and humanitarian assistance programs.
This bill would abolish the Fogarty International Center for Advanced Study in the Health Sciences. If enacted, it would end the center's operations and funding, directly affecting its staff and ongoing international health research programs. The legislation specifically targets the elimination of this National Institutes of Health division without altering broader health research policies.
HR 1137, the "No Kill Switches in Cars Act," repeals Section 24220 of the Infrastructure Investment and Jobs Act (Public Law 117-58), which previously required vehicle manufacturers to implement advanced impaired driving technology. This bill directly affects car manufacturers by removing a mandate to integrate specific safety technology designed to detect driver impairment. The key provision is the repeal itself, eliminating the requirement without creating new obligations or altering existing vehicle safety standards.
HR 1138, the Payment Choice Act of 2025, requires most retail businesses to accept cash for in-person purchases up to $500 per transaction and prohibits charging higher prices for cash payments compared to other methods. Businesses may temporarily refuse cash only due to system failures, insufficient change, or if they offer a prepaid card conversion device meeting strict conditions (no fees, no minimum deposit, no expiration). The bill allows businesses a 5-year period to phase in accepting $50 bills or larger, after which the Treasury Secretary must mandate acceptance of $1-$20 bills. Consumers can send a 45-day notice to businesses for violations before pursuing legal action, with potential damages of at least $250 per violation. The law does not override stricter state cash acceptance protections.
